Clinical trial
Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated…
NCT00281255 · University of Pennsylvania, Other · Withdrawn
Key facts
| NCT number | NCT00281255 |
|---|---|
| Title | Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy |
| Official title | Allopurinol and Cardiac Function Pilot Study in Idiopathic Dilated Cardiomyopathy |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Cardiomyopathy, Dilated, Heart Diseases, Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Allopurinol, Dobutamine |
| Enrollment | 0 |
| Start date | Jun 1, 2003 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Jan 24, 2006 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: